Clindamycin Phosphate NDC 63629-8629

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-8629Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-8629Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63629-8629-1	63629862901	1 CAN in 1 CARTON (63629-8629-1) / 100 g in 1 CANMarketed from Mar 31, 2010

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 10 mg/g
Dosage form: Aerosol, Foam
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090785
Marketing start: Mar 31, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 63629-8629_00b63f17-6efe-ac54-e063-6394a90a4832SPL ID 00b63f17-6efe-ac54-e063-6394a90a4832SPL set ID e8086cf9-aa52-4aa5-815b-c76e8f145e0bRxCUI 477451UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629862901 followed by a unit qualifier and the quantity

Package 63629-8629-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2023.

Indications (excerpt from the label)

Clindamycin Phosphate Foam, 1% is indicated for topical application in the treatment of acne vulgaris in patients 12 years and older. Clindamycin Phosphate Foam, 1% is a lincosamide product indicated for acne vulgaris in patients 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090785

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090785
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	Aerosol, FoamTopical	Padagis Israel Pharmaceuticals Ltd	45802-660
Clindacinclindamycin phosphate	Clindamycin phosphate 10 mg/g	Aerosol, FoamTopical	Medimetriks Pharmaceuticals, Inc.	43538-179
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	Aerosol, FoamTopical	Bryant Ranch Prepack	63629-8628